Cargando…

Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care

BACKGROUNDS: A desire for better outcome influences cancer patients’ willingness to pay. Whilst cancer-related costs are known to have a u-shaped distribution, the actual level of healthcare utilized by patients may vary depending on income and ability to pay. This study examined patterns of healthc...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Kyu-Tae, Kim, Woorim, Kim, Seungju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939210/
https://www.ncbi.nlm.nih.gov/pubmed/35317774
http://dx.doi.org/10.1186/s12885-022-09373-y
_version_ 1784672697264898048
author Han, Kyu-Tae
Kim, Woorim
Kim, Seungju
author_facet Han, Kyu-Tae
Kim, Woorim
Kim, Seungju
author_sort Han, Kyu-Tae
collection PubMed
description BACKGROUNDS: A desire for better outcome influences cancer patients’ willingness to pay. Whilst cancer-related costs are known to have a u-shaped distribution, the actual level of healthcare utilized by patients may vary depending on income and ability to pay. This study examined patterns of healthcare expenditures in the last year of life in patients with gastric, colorectal, lung, and liver cancer and analyzed whether differences exist in the level of end-of-life costs for cancer care according to economic status. METHODS: This study is a retrospective cohort study which used data from the Korean National Elderly Sampled Cohort, 2002 to 2015. End-of-life was defined as 1 year before death. Economic status was classified into three categorical variables according to the level of insurance premium (quantiles). The relationship between the dependent and independent variables were analyzed using multiple gamma regression based on the generalized estimated equation (GEE) model. RESULTS: This study included 3083 cancer patients, in which total healthcare expenditure was highest in the high-income group. End-of-life costs increased the most in the last 3 months of life. Compared to individuals in the ‘middle’ economic status group, those in the ‘high’ economic status group (RR 1.095, 95% CI 1.044–1.149) were likely to spend higher amounts. The percentage of individuals visiting a general hospital was highest in the ‘high’ economic status group, followed by the ‘middle’ and ‘low’ economic status groups. CONCLUSION: Healthcare costs for cancer care increased at end-of-life in Korea. Patients of higher economic status tended to spender higher amounts of end-of-life costs for cancer care. Further in-depth studies are needed considering that end-of-life medical costs constitute a large proportion of overall expenditures. This study offers insight by showing that expenditures for cancer care tend to increase noticeably in the last 3 months of life and that differences exist in the amount spent according economic status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09373-y.
format Online
Article
Text
id pubmed-8939210
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89392102022-03-23 Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care Han, Kyu-Tae Kim, Woorim Kim, Seungju BMC Cancer Research BACKGROUNDS: A desire for better outcome influences cancer patients’ willingness to pay. Whilst cancer-related costs are known to have a u-shaped distribution, the actual level of healthcare utilized by patients may vary depending on income and ability to pay. This study examined patterns of healthcare expenditures in the last year of life in patients with gastric, colorectal, lung, and liver cancer and analyzed whether differences exist in the level of end-of-life costs for cancer care according to economic status. METHODS: This study is a retrospective cohort study which used data from the Korean National Elderly Sampled Cohort, 2002 to 2015. End-of-life was defined as 1 year before death. Economic status was classified into three categorical variables according to the level of insurance premium (quantiles). The relationship between the dependent and independent variables were analyzed using multiple gamma regression based on the generalized estimated equation (GEE) model. RESULTS: This study included 3083 cancer patients, in which total healthcare expenditure was highest in the high-income group. End-of-life costs increased the most in the last 3 months of life. Compared to individuals in the ‘middle’ economic status group, those in the ‘high’ economic status group (RR 1.095, 95% CI 1.044–1.149) were likely to spend higher amounts. The percentage of individuals visiting a general hospital was highest in the ‘high’ economic status group, followed by the ‘middle’ and ‘low’ economic status groups. CONCLUSION: Healthcare costs for cancer care increased at end-of-life in Korea. Patients of higher economic status tended to spender higher amounts of end-of-life costs for cancer care. Further in-depth studies are needed considering that end-of-life medical costs constitute a large proportion of overall expenditures. This study offers insight by showing that expenditures for cancer care tend to increase noticeably in the last 3 months of life and that differences exist in the amount spent according economic status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09373-y. BioMed Central 2022-03-22 /pmc/articles/PMC8939210/ /pubmed/35317774 http://dx.doi.org/10.1186/s12885-022-09373-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Han, Kyu-Tae
Kim, Woorim
Kim, Seungju
Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
title Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
title_full Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
title_fullStr Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
title_full_unstemmed Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
title_short Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
title_sort disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939210/
https://www.ncbi.nlm.nih.gov/pubmed/35317774
http://dx.doi.org/10.1186/s12885-022-09373-y
work_keys_str_mv AT hankyutae disparitiesinhealthcareexpendituresaccordingtoeconomicstatusincancerpatientsundergoingendoflifecare
AT kimwoorim disparitiesinhealthcareexpendituresaccordingtoeconomicstatusincancerpatientsundergoingendoflifecare
AT kimseungju disparitiesinhealthcareexpendituresaccordingtoeconomicstatusincancerpatientsundergoingendoflifecare